Usability, Acceptability, and Usefulness of an mHealth App for Diagnosing and Monitoring Patients With Breakthrough Cancer Pain
Usability, Acceptability, and Usefulness of an mHealth App for Diagnosing and Monitoring Patients With Breakthrough Cancer Pain
复制标题
DOI：
10.2196/10187
复制
发表时间：
2019-04-01
期刊：
影响因子：
2.8
通讯作者：
Gonzalez, Gloria
中科院分区：
文献类型：
--
作者：
Boceta, Jaime;Samper, Daniel;Gonzalez, Gloria
背景：突破性疼痛是癌症患者的一个主要问题，也是痛苦的来源。我们假设，医疗保健专业人员可能会受益于实时移动的应用程序，以帮助诊断和监测突破性癌痛（BTcP）。目的：本研究旨在测试为管理BTcP患者而开发的移动的应用程序INES.DIO在现实世界实践中的可用性、可接受性和有用性。方法：本研究包括对175名医生的多学科样本进行的调查，这些医生在对4名BTcP患者（共700名患者）进行测试后对移动的应用程序进行了评估。医生的数字配置文件，使用的应用程序中包含的不同资源，有用的资源，可接受性，可用性，潜在的改进，意图使用，和额外的资源addressed.Results：在175名医生，96%（168/175）在公立医院工作。他们平均有12年（SD 7）的BTcP经验，几乎所有人（174/175，99.43%）都有活跃的数字档案。东部肿瘤协作组和Karnofsky性能量表、视觉焦虑量表和Davies算法是诊断BTcP的最常用工具，超过80%（140/175）的医生评估为非常有用。大多数人（157/175，90%）回答说，应用程序INES.DIO设计良好，94%（165/175）可能或非常可能推荐给其他同事。超过三分之二的人表示，该应用程序提供的报告值得纳入患者的临床记录。该应用程序中最有价值的资源是记录每天疼痛发作的次数、持续时间和强度以及基线疼痛控制，以增强BTcP的诊断。建议在未来版本的App INES.DIO.Conclusions中纳入其他以患者为导向的癌症疼痛教育内容：我们的研究表明，App INES .DIO易于使用，可用于医生帮助诊断和监测癌症患者的突破性疼痛。参与者建议实施有关突破性疼痛的额外教育内容。他们一致认为，增加新的临床指南/方案来管理BTcP，提高他们与患者的沟通技巧，并引入一个基于证据的视频平台，收集关于BTcP的新教育材料。
Background: Breakthrough pain is a major problem and a source of distress in patients with cancer. We hypothesized that health care professionals may benefit from a real-time mobile app to assist in the diagnosis and monitoring of breakthrough cancer pain (BTcP).Objective: This study aimed to test the usability, acceptability, and usefulness in real-world practice of the mobile App INES.DIO developed for the management of patients with BTcP.Methods: This study consisted of a survey of a multidisciplinary sample of 175 physicians who evaluated the mobile app after testing it with 4 patients with BTcP each (for a total of 700 patients). The digital profile of the physicians, use of the different resources contained in the app, usefulness of the resources, acceptability, usability, potential improvements, intention to use, and additional resources to add were recorded.Results: Of the 175 physicians, 96% (168/175) were working in public hospitals. They had an average of 12 (SD 7) years of experience in BTcP and almost all (174/175, 99.43%) had an active digital profile. The Eastern Cooperative Oncology Group and Karnofsky performance scales, the Visual Analogue Scale, and the Davies algorithm to diagnose BTcP were the most frequently used tools with patients and were assessed as very useful by more than 80% (140/175) of physicians. The majority (157/175, 90%) answered that App INES.DIO was well designed and 94% (165/175) would probably or very probably recommend it to other colleagues. More than two-thirds indicated that the report provided by the app was worth being included in patients' clinical records. The most valued resource in the app was the recording of the number, duration, and intensity of pain flares each day and baseline pain control to enhance diagnosis of BTcP. Additional patient-oriented cancer pain educational content was suggested for inclusion in future versions of App INES.DIO.Conclusions: Our study showed that App INES .DIO is easy to use and useful for physicians to help diagnose and monitor breakthrough pain in patients with cancer. Participants suggested the implementation of additional educational content about breakthrough pain. They agreed on the importance of adding new clinical guidelines/protocols for the management of BTcP, improving their communication skills with patients, and introducing an evidence based video platform that gathers new educational material on BTcP.